PRA Applauds President Trump's Drug Prices Executive Order

Today, Cynthia Fisher, Founder and Chairman of PatientRightsAdvocate.org, released the following statement applauding President Trump’s Drug Prices Executive Order.

“President Trump’s actions will give Americans savings in wages and take-home pay from egregious overcharges in drugs, healthcare, and coverage. This drug pricing policy and Radical Price Transparency will add savings to wages and families’ budgets, and allow workers, enterprises, and the American economy to better compete globally by unleashing fair market prices and competition to lower spending.”

About PRA

PatientRightsAdvocate.org (PRA) is a leading national healthcare price transparency organization dedicated to ushering in systemwide transparency through advocacy, testimony, media, legal research, and grassroots campaigns. PRA believes that the availability and visibility of actual, upfront healthcare prices will greatly lower costs for patients and employers through a functional, competitive healthcare marketplace.